Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Usana Health Sciences Inc (USNA)

Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 396,149
  • Shares Outstanding, K 18,281
  • Annual Sales, $ 854,500 K
  • Annual Income, $ 42,030 K
  • EBIT $ 42 M
  • EBITDA $ 64 M
  • 60-Month Beta 0.67
  • Price/Sales 0.41
  • Price/Cash Flow 5.44
  • Price/Book 0.70

Options Overview Details

View History
  • Implied Volatility 140.44% (-69.62%)
  • Historical Volatility 48.43%
  • IV Percentile 66%
  • IV Rank 47.81%
  • IV High 232.86% on 11/19/25
  • IV Low 55.80% on 08/13/25
  • Expected Move (DTE 26) 1.79 (8.24%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 17
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 1.77
  • Today's Open Interest 260
  • Open Int (30-Day) 228
  • Expected Range 19.89 to 23.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.44
  • Number of Estimates 1
  • High Estimate 0.44
  • Low Estimate 0.44
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -39.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.57 +16.69%
on 02/18/26
22.90 -5.37%
on 01/22/26
-0.30 (-1.37%)
since 01/20/26
3-Month
18.57 +16.69%
on 02/18/26
22.90 -5.37%
on 01/22/26
+3.00 (+16.07%)
since 11/20/25
52-Week
18.48 +17.26%
on 11/19/25
38.32 -43.45%
on 07/23/25
-10.42 (-32.47%)
since 02/20/25

Most Recent Stories

More News
Why USANA (USNA) Stock Is Down Today

Why USANA (USNA) Stock Is Down Today

USNA : 21.67 (+5.45%)
USNA Q4 Deep Dive: Omnichannel Push and Brand Expansion Shape Outlook Amid Margin Pressures

USNA Q4 Deep Dive: Omnichannel Push and Brand Expansion Shape Outlook Amid Margin Pressures

USNA : 21.67 (+5.45%)
USANA Health: Q4 Earnings Snapshot

USANA Health: Q4 Earnings Snapshot

USNA : 21.67 (+5.45%)
USANA’s (NYSE:USNA) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

USANA’s (NYSE:USNA) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

USNA : 21.67 (+5.45%)
USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results...

USNA : 21.67 (+5.45%)
USANA (USNA) To Report Earnings Tomorrow: Here Is What To Expect

USANA (USNA) To Report Earnings Tomorrow: Here Is What To Expect

USNA : 21.67 (+5.45%)
3 Reasons to Avoid USNA and 1 Stock to Buy Instead

3 Reasons to Avoid USNA and 1 Stock to Buy Instead

USNA : 21.67 (+5.45%)
3 Value Stocks with Warning Signs

3 Value Stocks with Warning Signs

PKOH : 27.01 (+0.11%)
USNA : 21.67 (+5.45%)
CDW : 124.64 (+0.38%)
USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28 th ...

USNA : 21.67 (+5.45%)
1 Russell 2000 Stock for Long-Term Investors and 2 We Find Risky

1 Russell 2000 Stock for Long-Term Investors and 2 We Find Risky

CCB : 83.65 (-0.38%)
USNA : 21.67 (+5.45%)
HLIO : 74.23 (+0.73%)

Business Summary

USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network...

See More

Key Turning Points

3rd Resistance Point 24.61
2nd Resistance Point 23.42
1st Resistance Point 22.54
Last Price 21.67
1st Support Level 20.47
2nd Support Level 19.28
3rd Support Level 18.40

See More

52-Week High 38.32
Fibonacci 61.8% 30.74
Fibonacci 50% 28.40
Fibonacci 38.2% 26.06
Last Price 21.67
52-Week Low 18.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar